Innovation Pharmaceuticals Inc.
IPIX
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 864.00K | 1.52M | 1.94M | 2.42M | 2.97M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 76.00K | 116.00K | -- | 101.00K | 122.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 940.00K | 1.63M | 1.94M | 2.52M | 3.09M |
|
|
|||||
| Total Current Assets | 940.00K | 1.63M | 1.94M | 2.52M | 3.09M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.91M | 2.00M | 2.08M | 2.16M | 2.22M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 78.00K | 78.00K | 78.00K | 78.00K | 78.00K |
| Total Assets | 6.67M | 7.52M | 7.99M | 8.69M | 9.34M |
|
|
|||||
| Total Accounts Payable | 3.02M | 1.50M | 1.21M | 1.21M | 1.43M |
| Total Accrued Expenses | 1.78M | 1.76M | 1.76M | 1.73M | 1.74M |
| Short-term Debt | 238.00K | 213.00K | 238.00K | 235.00K | 244.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 55.00K | 108.00K | 158.00K | 206.00K |
| Total Finance Division Other Current Liabilities | 11.50K | 1.49M | 1.50M | 1.50M | 1.51M |
| Total Other Current Liabilities | 11.50K | 1.49M | 1.50M | 1.50M | 1.51M |
| Total Current Liabilities | 5.05M | 5.02M | 4.82M | 4.82M | 5.13M |
|
|
|||||
| Total Current Liabilities | 5.05M | 5.02M | 4.82M | 4.82M | 5.13M |
| Long-Term Debt | 457.00K | 457.00K | 457.00K | 786.00K | 786.00K |
| Short-term Debt | 238.00K | 213.00K | 238.00K | 235.00K | 244.00K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.51M | 5.48M | 5.28M | 5.61M | 5.92M |
|
|
|||||
| Common Stock & APIC | 129.62M | 129.62M | 129.61M | 129.28M | 129.26M |
| Retained Earnings | -126.21M | -125.33M | -124.64M | -123.95M | -123.59M |
| Treasury Stock & Other | -2.25M | -2.25M | -2.25M | -2.25M | -2.25M |
| Total Common Equity | 1.16M | 2.04M | 2.72M | 3.08M | 3.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.16M | 2.04M | 2.72M | 3.08M | 3.42M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.16M | 2.04M | 2.72M | 3.08M | 3.42M |
|
|
|||||